News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-19 1:7:11 pm XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc. GlobeNewsWire
2024-03-08 5:12:7 am XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023 GuruFocus.com
2024-03-08 4:52:40 am Xoma: Q4 Earnings Snapshot Associated Press Finance
2024-03-08 4:30:0 am XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value GlobeNewswire
2024-02-28 4:30:0 am XOMA to Present at Upcoming Investor Conferences in March GlobeNewswire
2024-02-16 5:0:0 am XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right GlobeNewswire
2024-01-20 6:26:28 am With 37% ownership, XOMA Corporation (NASDAQ:XOMA) has piqued the interest of institutional investors Simply Wall St.
2024-01-18 5:30:0 am XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition GlobeNewswire
2024-01-11 1:5:0 pm FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information